Sevenfact Kit
Product Images NDC 71127-5000

27 FDA label images from Laboratoire Fran�ais Du Fractionnement Et Des Biotechnologies Soci�t� Anonyme (lfb S.a.) · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 27 technical images submitted to the FDA as part of the official labeling for Sevenfact (NDC 71127-5000). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Laboratoire Fran�ais Du Fractionnement Et Des Biotechnologies Soci�t� Anonyme (lfb S.a.), these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lyophilized Powder Drug Vial (Recombinant 01)

Lyophilized Powder Drug Vial (Recombinant 01)
An illustration of a vial showing a plastic cap covering a rubber stopper. The diagram labels the plastic cap on top and indicates the rubber stopper beneath the plastic cap on the vial.*
FDA Label Image

Syringe Plunger Rodpre-filled Syringe With Diluent (Recombinant 02)

Syringe Plunger Rodpre-filled Syringe With Diluent (Recombinant 02)
An instructional line drawing illustrating the parts of a syringe assembly for intravenous use. The diagram labels the wide top, thread, plastic backstop, rubber stopper, syringe tip (with a note about a Luer lock top under the syringe cap), and the syringe cap.*
FDA Label Image

Vial Adapters* And Packaging (Recombinant 03)

Vial Adapters* And Packaging (Recombinant 03)
An instructional illustration showing a syringe cap with a spike covered by protective paper, along with a plastic cover and paper protective cover. The diagram labels these components to clarify their arrangement and protective features for safe use.*
FDA Label Image

Powdered Drug Vial (Recombinant 06)

Powdered Drug Vial (Recombinant 06)
An instructional illustration depicting a powdered drug vial with labels identifying its components: a plastic cap and a rubber stopper beneath the plastic cap. The vial is shown in a labeled diagram format, useful for understanding packaging or preparation of the drug.*
FDA Label Image

Syringe Plunger Rod Prefilled Syringe With Diluent (Recombinant 07)

Syringe Plunger Rod Prefilled Syringe With Diluent (Recombinant 07)
An instructional illustration showing the components of a syringe plunger rod and a prefilled syringe with diluent. The syringe plunger rod is labeled with a wide top and thread. The prefilled syringe is labeled with a plastic backstop, rubber stopper, syringe tip (noting a Luer lock top under the syringe cap), and syringe cap.*
FDA Label Image

Vial Adapters* And Packaging (Recombinant 08)

Vial Adapters* And Packaging (Recombinant 08)
An instructional diagram showing two types of vial adapters for the Sevenfact kit: a 1 mg vial adapter and a 5 mg vial adapter. Each adapter includes a plastic cover, spike (under protective paper), and a paper protective cover. A syringe cap is also shown for the 1 mg adapter. A note indicates that the Sevenfact kit will contain only one vial adapter.*
FDA Label Image

Infusion Set Plastic Syring Alcohol Swab Fda-approved Sharps Container (Recombinant 09)

Infusion Set Plastic Syring Alcohol Swab Fda-approved Sharps Container (Recombinant 09)
Illustration showing components of a Sevenfact infusion kit, including an infusion set, a plastic syringe, an alcohol swab, and an FDA-approved sharps container labeled with a biohazard symbol.*
FDA Label Image

Figure A (Recombinant 0a)

Figure A (Recombinant 0a)
The packaging label for Sevenfact, a kit containing Coagulation Factor VIIa Recombinant Human for intravenous use. The label features the brand name Sevenfact prominently, with part of the generic name visible. There is a section marked with a magnified eye symbol highlighting a barcode area containing GTIN, serial number, lot number, and expiration date fields. The labeler is Laboratoire Français du Fractionnement et des Biotechnologies Société Anonyme (LFB S.A.).*
FDA Label Image

Figure B (Recombinant 0b)

Figure B (Recombinant 0b)
Illustration showing a hand being washed under running water from a faucet, with another hand rubbing the fingers, labeled with a black square containing the letter B. This instructional image likely demonstrates proper hand hygiene technique related to use or preparation of the product.*
FDA Label Image

Figure C (Recombinant 0c)

Figure C (Recombinant 0c)
Illustration showing the Sevenfact kit for intravenous use, including packaging and kit contents displayed on a table: a syringe, a vial, a small packet labeled 'Multi-Dose,' and a lancet device. The image emphasizes the individual components contained within the Sevenfact coagulation factor VIIa recombinant human kit by LFB S.A.*
FDA Label Image

Figure D (Recombinant 0d)

Figure D (Recombinant 0d)
An instructional illustration showing a hand holding a vial labeled Sevenfact. The image demonstrates how to grip the vial, likely as part of preparation or administration instructions for the Sevenfact coagulation factor VIIa recombinant human intravenous kit by LFB S.A.*
FDA Label Image

Figure E (Recombinant 0e)

Figure E (Recombinant 0e)
An instructional illustration showing a hand holding a vial while another hand peels off or cleans the vial's stopper with an alcohol wipe or similar cloth. The image is labeled with the letter "E" in a black box in the lower left corner.*
FDA Label Image

Figure F (Recombinant 0f)

Figure F (Recombinant 0f)
An instructional illustration labeled 'F' showing hands peeling back a peel-off plastic cover from a round vial or container, likely part of preparing a Sevenfact kit for intravenous use.*
FDA Label Image

Figure G (Recombinant 10)

Figure G (Recombinant 10)
An instructional illustration showing hands preparing medication using a vial and a syringe or similar device. An inset diagram highlights placing the assembled syringe apparatus into a holder or stand, indicated by a black arrow. The illustration is labeled with a bold letter 'G' in the corner.*
FDA Label Image

Figure H (Recombinant 11)

Figure H (Recombinant 11)
An instructional illustration showing hands removing two tablets or capsules from a blister pack and holding a vial, likely demonstrating preparation steps for the Sevenfact kit containing Coagulation Factor VIIa Recombinant Human for intravenous use.*
FDA Label Image

Figrue I (Recombinant 12)

Figrue I (Recombinant 12)
An instructional illustration showing a step in preparation or assembly, where a hand is twisting and attaching a vial or cap to another component, indicated by arrows to guide the motion.*
FDA Label Image

Figure J (Recombinant 13)

Figure J (Recombinant 13)
An instructional illustration showing a hand using a syringe to withdraw medication from a vial. The image demonstrates the correct method to draw liquid from the vial into the syringe, with arrows indicating the motion and a label 'J' in the bottom left corner.*
FDA Label Image

Figure K (Recombinant 14)

Figure K (Recombinant 14)
An instructional illustration showing a close-up of two hands manipulating a syringe and vial. The upper hand is shown twisting or rotating the syringe plunger, with curved arrows indicating the direction of rotation. The vial is positioned below the syringe on a flat surface. A black square with the letter 'K' appears in the lower left corner of the image.*
FDA Label Image

Figure L (Recombinant 15)

Figure L (Recombinant 15)
An instructional diagram showing the use of a syringe to draw liquid from a vial labeled with an 'L' in a black square. The illustration depicts two hands, one holding the syringe needle inserted into the vial and the other steadying the vial, with a downward arrow indicating the drawing motion.*
FDA Label Image

Figure M (Recombinant 16)

Figure M (Recombinant 16)
An instructional illustration showing hands gently swirling a vial with a syringe. The image emphasizes a gentle swirling motion, indicated by curved arrows, to probably mix or dissolve the contents without shaking. The letter 'M' appears in a black square on the lower left corner.*
FDA Label Image

Figure N (Recombinant 17)

Figure N (Recombinant 17)
An instructional illustration showing a vial with a dropper or syringe attached at the top. An arrow points downward into the vial, with an eye icon beside it, indicating to visually inspect the vial's contents. The letter "N" is present in a black box at the lower left corner.*
FDA Label Image

Figure O (Recombinant 18)

Figure O (Recombinant 18)
An instructional illustration showing the hands performing a step in medication preparation. One hand holds a vial or container while the other hand is removing or inserting a syringe or similar device vertically above it, with arrows indicating upward and rotational movement.*
FDA Label Image

Figure P (Recombinant 19)

Figure P (Recombinant 19)
An instructional illustration showing a hand disposing of a syringe into a biohazard sharps container labeled with a biohazard symbol and the words 'SHARPS CONTAINER.' This image is likely part of patient or healthcare provider guidance for safe injection waste disposal.*
FDA Label Image

Figure Q (Recombinant 1a)

Figure Q (Recombinant 1a)
An instructional illustration depicting a clock showing 3:00 with the accompanying text 'Infuse within 4 Hours,' indicating the time frame for infusion after preparation.*
FDA Label Image

Figure R (Recombinant 1b)

Figure R (Recombinant 1b)
An instructional illustration showing a hand safely disposing of a syringe or vial into a rectangular sharps container labeled 'SHARPS CONTAINER' with a biohazard symbol. The image includes a bold letter 'R' in the lower left corner.*
FDA Label Image

Sevenfactcoagulation Factor Viia (recombinant)-jncw 1 mg (Recombinant 1c)

Sevenfactcoagulation Factor Viia (recombinant)-jncw 1 mg (Recombinant 1c)
Sevenfact 1 mg kit carton label for coagulation factor VIIa (recombinant) - jncw. The packaging indicates room temperature stability with instructions not to freeze. Labeler is Laboratoire Français du Fractionnement et des Biotechnologies Société Anonyme (LFB S.A.) with distribution by HEMA Biologics. The label includes usage directions and storage warnings, barcodes, and manufacturer details.*
FDA Label Image

Sevenfactcoagulation Factor Viia (recombinant)-jncw 5 mg (Recombinant 1d)

Sevenfactcoagulation Factor Viia (recombinant)-jncw 5 mg (Recombinant 1d)
Sevenfact 5 mg packaging label for coagulation factor VIIa (recombinant) intravenous kit. The label shows the proprietary name Sevenfact with strength 5 mg, details on the recombinant factor VIIa, warnings including 'Room temperature stable. Do not freeze.', and reconstitution instructions. The labeler is Laboratoire Français du Fractionnement et des Biotechnologies Société Anonyme (LFB S.A.), with HEMA Biologics mentioned as distributor.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.